Webinar: Ultrafast Sequencing Services Accelerate Every Stage of Gene and Cell Therapy Research

What if sequencing could keep pace with the speed of your cell and gene therapy research?

In this presentation, Mark Budde, Co-Founder and CEO of Plasmidsaurus, shares how Plasmidsaurus is helping researchers accelerate biotech research with fast, high-quality sequencing and analysis.

Starting with whole plasmid sequencing, Plasmidsaurus was built to address a common bottleneck in molecular biology: waiting for sequencing results. Today, its sequencing services support researchers across the workflow, from plasmid verification and gene editing to RNA-Seq, genotyping, cell therapy, viral vectors, and more.

In this video, Mark covers:

• Whole plasmid sequencing: How sequencing entire plasmids can reveal mutations and backbone heterogeneity that traditional Sanger sequencing may miss, with automated assembly, annotation, variant detection, and interactive results.

• Genotyping and variant analysis: A look at Plasmidsaurus’ genotyping analysis for identifying alleles, measuring variant frequencies, and resolving phased variants for applications including CRISPR gene editing, mouse transgenics, genetic crosses, and quality control.

• RNA-Seq: How fast, accessible RNA-Seq can provide transcriptome-wide insight into gene expression, differential expression, and pathway activity, with sequencing and bioinformatics included.

• Sequencing for biotechs: How Plasmidsaurus supports workflows spanning plasmids, CRISPR systems, cell therapy, CAR-T, AAV, viral vectors, microbiome sequencing, whole genome sequencing, and custom workflows.

Our goal is is to make sequencing less of a bottleneck so researchers can sequence at the speed of their experiments.